CS logo
small CS logo
New York State Psychiatric Institute

New York, New York, United States
Medical center in New York City, New York
1051 Riverside Dr, New York, NY 10032

About New York State Psychiatric Institute


The New York State Psychiatric Institute, located at the Columbia University Irving Medical Center in the Washington Heights neighborhood of Manhattan, New York City, was established in 1895 as one of ...
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
New York State Psychiatric Institute
244
Research Foundation for Mental Hygiene, Inc.
15
National Institute on Drug Abuse (NIDA)
10
Boehringer Ingelheim
4
Columbia University
4
Alkermes, Inc.
2
Biohaven Pharmaceuticals, Inc.
2
COMPASS Pathways
2
Center for Social Innovation, Massachusetts
2
Hoffmann-La Roche
2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
2
Total Rows: 37

Clinical Trials at New York State Psychiatric Institute


During the past decade, New York State Psychiatric Institute conducted 131 clinical trials. In the 10-year time frame, 131 clinical trials started and 125 clinical trials were completed, i.e. on average, 95.4% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 50 clinical trials were completed. i.e. 96.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years151515151818111120201010232315154433111138381111121217171313141466Started TrialsCompleted Trails20152016201720182019202020212022202302040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
1994-08-01
2001-12-01
Completed
0
Risperidone Treatment in Dually-Diagnosed Individuals - 2
2001-12-01
Completed
0
Cocaine Abuse and Attention Deficit Disorder - 3
1995-05-01
1998-11-01
Completed
32
Pergolide Treatment for Substance Abusers - 4
1995-10-01
2001-12-01
Completed
0
Brain Imaging: Cocaine Effects & Medication Development - 5
1995-12-30
1995-12-30
Withdrawn
0
A Laboratory Model for Heroin Abuse Medications - 8
1995-08-01
2005-11-01
Completed
8
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
1997-03-01
1999-05-01
Completed
60
Cocaine Abuse and ADHD - 10
1996-11-01
1998-03-01
Completed
16

Rows per page:

1–100 of 317

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "New York State Psychiatric Institute" #1 sponsor was "New York State Psychiatric Institute" with 244 trials, followed by "Research Foundation for Mental Hygiene, Inc." with 15 trials sponsored, "National Institute on Drug Abuse (NIDA)" with 10 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Columbia University" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "New York State Psychiatric Institute" #1 collaborator was "National Institute of Mental Health (NIMH)" with 73 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 48 trials as a collaborator, "Columbia University" with 26 trials as a collaborator, "New York State Psychiatric Institute" with 13 trials as a collaborator and "Research Foundation for Mental Hygiene, Inc." with 10 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 90 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at New York State Psychiatric Institute


According to Clinical.Site data, the most researched conditions in "New York State Psychiatric Institute" are "Major Depressive Disorder" (29 trials), "Depression" (25 trials), "Schizophrenia" (24 trials), "Obsessive-Compulsive Disorder" (15 trials) and "Anorexia Nervosa" (13 trials). Many other conditions were trialed in "New York State Psychiatric Institute" in a lesser frequency.

Clinical Trials Intervention Types at New York State Psychiatric Institute


Most popular intervention types in "New York State Psychiatric Institute" are "Drug" (202 trials), "Behavioral" (95 trials), "Other" (26 trials), "Device" (22 trials) and "Procedure" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (62 trials), "Ketamine" (9 trials), "Cannabis" (7 trials), "Naltrexone" (7 trials) and "Fluoxetine" (6 trials). Other intervention names were less common.

Clinical Trials Genders at New York State Psychiatric Institute


The vast majority of trials in "New York State Psychiatric Institute" are 298 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Clinical Trials Status at New York State Psychiatric Institute


Currently, there are 52 active trials in "New York State Psychiatric Institute". 3 are not yet recruiting, 39 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 209 completed trials in New York State Psychiatric Institute, 4 suspended trials, and 36 terminated clinical trials to date.
Out of the total trials that were conducted in New York State Psychiatric Institute, 42 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 61 trials, and there were also 88 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status